These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33319073)

  • 1. Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac - Feasibility, workflow data and patient acceptance.
    Gani C; Boeke S; McNair H; Ehlers J; Nachbar M; Mönnich D; Stolte A; Boldt J; Marks C; Winter J; Künzel LA; Gatidis S; Bitzer M; Thorwarth D; Zips D
    Clin Transl Radiat Oncol; 2021 Jan; 26():55-61. PubMed ID: 33319073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local control and patient reported outcomes after online MR guided stereotactic body radiotherapy of liver metastases.
    Uder L; Nachbar M; Butzer S; Boldt J; Baumeister S; Bitzer M; Königsrainer A; Seufferlein T; Hoffmann R; Gatidis S; Nikolaou K; Zips D; Thorwarth D; Gani C; Boeke S
    Front Oncol; 2022; 12():1095633. PubMed ID: 36727060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
    Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
    Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience.
    Sahin B; Zoto Mustafayev T; Gungor G; Aydin G; Yapici B; Atalar B; Ozyar E
    Cureus; 2019 Dec; 11(12):e6457. PubMed ID: 32025388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI-Guided Online Adaptive Stereotactic Body Radiation Therapy of Liver and Pancreas Tumors on an MR-Linac System.
    Stanescu T; Shessel A; Carpino-Rocca C; Taylor E; Semeniuk O; Li W; Barry A; Lukovic J; Dawson L; Hosni A
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Tumors: Initial Clinical Experience and Patient-Reported Outcomes.
    Weykamp F; Hoegen P; Klüter S; Spindeldreier CK; König L; Seidensaal K; Regnery S; Liermann J; Rippke C; Koerber SA; Buchele C; Debus J; Hörner-Rieber J
    Front Oncol; 2021; 11():610637. PubMed ID: 34178616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time Magnetic Resonance-guided Liver Stereotactic Body Radiation Therapy: An Institutional Report Using a Magnetic Resonance-Linac System.
    Feldman AM; Modh A; Glide-Hurst C; Chetty IJ; Movsas B
    Cureus; 2019 Sep; 11(9):e5774. PubMed ID: 31723533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience.
    Paulson ES; Ahunbay E; Chen X; Mickevicius NJ; Chen GP; Schultz C; Erickson B; Straza M; Hall WA; Li XA
    Clin Transl Radiat Oncol; 2020 Jul; 23():72-79. PubMed ID: 32490218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic Magnetic Resonance-Guided Adaptive and Non-Adaptive Radiotherapy on Combination MR-Linear Accelerators: Current Practice and Future Directions.
    Bryant JM; Weygand J; Keit E; Cruz-Chamorro R; Sandoval ML; Oraiqat IM; Andreozzi J; Redler G; Latifi K; Feygelman V; Rosenberg SA
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the impact of patient arm position in an MR-linac on liver SBRT treatment plans.
    van den Wollenberg W; de Ruiter P; Nowee ME; Jansen EPM; Sonke JJ; Fast MF
    Med Phys; 2019 Nov; 46(11):5144-5151. PubMed ID: 31529694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac.
    Hall WA; Straza MW; Chen X; Mickevicius N; Erickson B; Schultz C; Awan M; Ahunbay E; Li XA; Paulson ES
    PLoS One; 2020; 15(8):e0236570. PubMed ID: 32764748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Outcomes of Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Adrenal Metastases from a Single Institution.
    Hoegen-Saßmannshausen P; Jessen I; Buchele C; Schlüter F; Rippke C; Renkamp CK; Weykamp F; Regnery S; Liermann J; Meixner E; Hoeltgen L; Eichkorn T; König L; Debus J; Klüter S; Hörner-Rieber J
    Cancers (Basel); 2024 Jun; 16(12):. PubMed ID: 38927978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Online adaptive MR-guided stereotactic radiotherapy for unresectable malignancies in the upper abdomen using a 1.5T MR-linac.
    Daamen LA; de Mol van Otterloo SR; van Goor IWJM; Eijkelenkamp H; Erickson BA; Hall WA; Heerkens HD; Meijer GJ; Molenaar IQ; van Santvoort HC; Verkooijen HM; Intven MPW
    Acta Oncol; 2022 Jan; 61(1):111-115. PubMed ID: 34879792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time motion-including dose estimation of simulated multi-leaf collimator-tracked magnetic resonance-guided radiotherapy.
    Persson E; Goodwin E; Eiben B; Wetscherek A; Nill S; Oelfke U
    Med Phys; 2024 Mar; 51(3):2221-2229. PubMed ID: 37898109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT).
    Wolfe S; Diven MA; Marciscano AE; Zhou XK; Kishan AU; Steinberg ML; Miccio JA; Camilleri P; Nagar H
    BMC Cancer; 2023 Sep; 23(1):923. PubMed ID: 37777738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technical feasibility and clinical evaluation of 4D-MRI guided liver SBRT on the MR-linac.
    van de Lindt TN; Nowee ME; Janssen T; Schneider C; Remeijer P; van Pelt VWJ; Betgen A; Jansen EPM; Sonke JJ
    Radiother Oncol; 2022 Feb; 167():285-291. PubMed ID: 35033603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and Early Clinical Experience of Online Adaptive MR-Guided Radiotherapy of Liver Tumors.
    Rogowski P; von Bestenbostel R; Walter F; Straub K; Nierer L; Kurz C; Landry G; Reiner M; Auernhammer CJ; Belka C; Niyazi M; Corradini S
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33810244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance-Guided Radiotherapy.
    Westerhoff JM; Daamen LA; Christodouleas JP; Blezer ELA; Choudhury A; Westley RL; Erickson BA; Fuller CD; Hafeez S; van der Heide UA; Intven MPW; Kirby AM; Lalondrelle S; Minsky BD; Mook S; Nowee ME; Marijnen CAM; Orrling KM; Sahgal A; Schultz CJ; Faivre-Finn C; Tersteeg RJHA; Tree AC; Tseng CL; Schytte T; Silk DM; Eggert D; Luzzara M; van der Voort van Zyp JRN; Verkooijen HM; Hall WA
    JAMA Netw Open; 2024 May; 7(5):e2410819. PubMed ID: 38691356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiotherapy of central lung tumours using a 1.5 T MR-linac: First clinical experiences.
    Merckel LG; Pomp J; Hackett SL; van Lier ALHMW; van den Dobbelsteen M; Rasing MJA; Mohamed Hoesein FAA; Snoeren LMW; van Es CA; van Rossum PSN; Fast MF; Verhoeff JJC
    Clin Transl Radiat Oncol; 2024 Mar; 45():100744. PubMed ID: 38406645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments.
    Chuong MD; Clark MA; Henke LE; Kishan AU; Portelance L; Parikh PJ; Bassetti MF; Nagar H; Rosenberg SA; Mehta MP; Refaat T; Rineer JM; Smith A; Seung S; Zaki BI; Fuss M; Mak RH
    Clin Transl Radiat Oncol; 2023 Jan; 38():161-168. PubMed ID: 36466748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.